Try our mobile app

Switch to company model in classical logic    *

General information

Country: IRELAND

Sector: Medical Devices

STERIS Public Limited Company operates as a provider of infection prevention and other procedural products and services. The Company offers sterilizers and washers, surgical tables, lights and equipment management systems, and endoscopy accessories. STERIS serves healthcare, pharmaceutical, and medical device industries.
Website: steris.com



Growth: Good revenue growth rate 14.8%, there is slowdown compared to average historical growth rates 22.5%. The revenue growth dynamics is moderately stable Site traffic for the last 3 months showed a change of +52.3%

Profitability: LTM EBITDA margin is positive, +27.4%. On average the margin is improving unsteadily. Gross margin is high, +43.2%. In the last quarter the company beat the estimated EPS, +7.0%. The company was ahead of estimated EPS in 60% of quarters (showing a gain of $0.00 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 1.0%. Free cash flow yield -1.4% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 27.2% higher than minimum and 19.2% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.7x by EV / Sales multiple , the company can be 1.2% overvalued

Key Financials (Download financials)

Ticker: STE
Share price, USD:  (+1.4%)204.44
year average price 217.23  


year start price 188.55 2023-04-28

min close price 187.12 2023-05-09

max close price 236.03 2024-02-22

current price 204.44 2024-04-26
Common stocks: 98 708 000

Dividend Yield:  1.0%
FCF Yield LTM: -1.4%
EV / LTM EBITDA: 13.6x
EV / EBITDA annualized: 13.9x
Last revenue growth (y/y):  14.8%
Last growth of EBITDA (y/y):  61.5%
Historical revenue growth:  22.5%
Historical growth of EBITDA:  34.5%
EV / Sales: 3.7x
Margin (EBITDA LTM / Revenue): 27.4%
Fundamental value created in LTM:
Market Cap ($m): 20 180
Net Debt ($m): 17
EV (Enterprise Value): 20 197
Price to Book: 3.1x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-22Zacks Investment Research

Should You Buy STERIS (STE) Stock Ahead of Q4 Earnings?

2024-04-09Zacks Investment Research

Here's Why Steris (STE) is Poised for a Turnaround After Losing -9.06% in 4 Weeks

2024-03-28Zacks Investment Research

Here's Why Investors Should Retain STERIS (STE) Stock for Now

2024-02-27Zacks Investment Research

Here's Why Investors Should Retain STERIS (STE) Stock for Now

2024-02-15Zacks Investment Research

Why Steris (STE) is a Top Momentum Stock for the Long-Term

2024-02-12Zacks Investment Research

Why Steris (STE) is a Top Growth Stock for the Long-Term

2024-02-08Zacks Investment Research

STERIS (STE) Q3 Earnings Top Estimates, Fiscal '24 Sales View Up

2024-02-07Zacks Investment Research

Compared to Estimates, Steris (STE) Q3 Earnings: A Look at Key Metrics

2024-02-07Zacks Investment Research

Steris (STE) Q3 Earnings and Revenues Top Estimates

2024-02-02Zacks Investment Research

Countdown to Steris (STE) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol STE STE STE STE STE STE
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-08 2023-11-07 2023-08-08 2023-05-10 2023-02-08 2022-11-09
acceptedDate 2024-02-08 16:36:30 2023-11-07 16:39:30 2023-08-08 16:53:43 2023-05-10 16:36:57 2023-02-08 16:34:46 2022-11-09 16:38:31
calendarYear 2024.000 2024.000 2024.000 2023.000 2023.000 2023.000
period Q3 Q2 Q1 Q4 Q3 Q2
revenue 1 396M 1 342M 1 285M 1 385M 1 216M 1 201M
costOfRevenue 793M 749M 711M 797M 694M 668M
grossProfit 603M 594M 573M 588M 521M 532M
grossProfitRatio 0.432 0.442 0.446 0.425 0.429 0.443
researchAndDevelopmentExpenses 26M 27M 26M 26M 26M 25M
generalAndAdministrativeExpenses 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 361M 381M 359M 336M 305M 323M
otherExpenses 6000.000 -36M -31M -30M -30M 0
operatingExpenses 386M 408M 385M 362M 331M 348M
costAndExpenses 1 179M 1 157M 1 096M 1 159M 1 025M 1 016M
interestIncome 2M 1M 1M 0 0 0
interestExpense 39M 37M 32M 30M 30M 27M
depreciationAndAmortization 141M 152M 38 000 716 000 138M 134M
ebitda 359M 186M 189M 226M 191M 318M
ebitdaratio 0.257 0.138 0.147 0.163 0.157 0.265
operatingIncome 216M 186M 189M 225M 53M 184M
operatingIncomeRatio 0.155 0.138 0.147 0.163 0.044 0.153
totalOtherIncomeExpensesNet -6000.000 -36M -31M -31M 107M -517M
incomeBeforeTax 179M 150M 158M 195M 160M -333M
incomeBeforeTaxRatio 0.128 0.112 0.123 0.141 0.132 -0.277
incomeTaxExpense 38M 34M 34M 8M 37M -18M
netIncome 141M 115M 124M 187M 124M -315M
netIncomeRatio 0.101 0.086 0.096 0.135 0.102 -0.263
eps 1.420 1.170 1.250 1.890 1.240 -3.150
epsdiluted 1.420 1.160 1.250 1.880 1.240 -3.150
weightedAverageShsOut 99M 99M 99M 99M 100M 100M
weightedAverageShsOutDil 99M 99M 99M 100M 100M 100M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol STE STE STE STE STE STE
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-08 2023-11-07 2023-08-08 2023-05-10 2023-02-08 2022-11-09
acceptedDate 2024-02-08 16:36:30 2023-11-07 16:39:30 2023-08-08 16:53:43 2023-05-10 16:36:57 2023-02-08 16:34:46 2022-11-09 16:38:31
calendarYear 2024.000 2024.000 2024.000 2023.000 2023.000 2023.000
period Q3 Q2 Q1 Q4 Q3 Q2
cashAndCashEquivalents 196M 214M 209M 208M 259M 258M
shortTermInvestments 0 0 0 0 0 0
cashAndShortTermInvestments 196M 214M 209M 208M 259M 258M
netReceivables 964M 940M 888M 928M 823M 780M
inventory 856M 821M 769M 695M 694M 645M
otherCurrentAssets 204M 199M 166M 179M 200M 205M
totalCurrentAssets 2 219M 2 174M 2 031M 2 011M 1 977M 1 888M
propertyPlantEquipmentNet 2 040M 1 936M 1 921M 1 897M 1 858M 1 746M
goodwill 4 112M 4 040M 3 887M 3 879M 3 853M 3 705M
intangibleAssets 2 987M 3 058M 2 865M 2 956M 3 031M 3 077M
goodwillAndIntangibleAssets 7 099M 7 098M 6 752M 6 835M 6 884M 6 783M
longTermInvestments -621M -613M -618M 0 0 0
taxAssets 621M 613M 618M 0 725M 0
otherNonCurrentAssets 77M 73M 80M 78M -644M 72M
totalNonCurrentAssets 9 216M 9 107M 8 753M 8 810M 8 823M 8 601M
otherAssets 0 0 0 0 0 0
totalAssets 11 435M 11 281M 10 784M 10 822M 10 800M 10 490M
accountPayables 277M 294M 261M 280M 242M 233M
shortTermDebt 115M 71M 63M 95M 95M 185M
taxPayables 25M 32M 64M 44M 25M 17M
deferredRevenue 90M 32M -63M 92M 100M 98M
otherCurrentLiabilities 431M 476M 626M 395M 359M 356M
totalCurrentLiabilities 914M 873M 887M 862M 796M 873M
longTermDebt 3 394M 3 366M 2 860M 3 019M 3 002M 3 017M
deferredRevenueNonCurrent 56M -613M -618M 0 0 0
deferredTaxLiabilitiesNonCurrent 621M 613M 618M 618M 725M 710M
otherNonCurrentLiabilities 23M 852M 859M 237M 229M 3 287M
totalNonCurrentLiabilities 4 093M 4 218M 3 719M 3 873M 3 955M 3 803M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 200M 162M 165M 195M 191M 177M
totalLiabilities 5 007M 5 091M 4 606M 4 735M 4 751M 4 676M
preferredStock 0 0 0 0 0 0
commonStock 4 534M 4 519M 4 498M 4 486M 4 632M 4 705M
retainedEarnings 2 134M 2 046M 1 981M 1 912M 1 771M 1 695M
accumulatedOtherComprehensiveIncomeLoss -253M -387M -311M -321M -364M -598M
othertotalStockholdersEquity 0 11M 10M 10M 10M 0
totalStockholdersEquity 6 415M 6 189M 6 178M 6 087M 6 049M 5 802M
totalEquity 6 428M 6 200M 6 188M 6 097M 6 049M 5 802M
totalLiabilitiesAndStockholdersEquity 11 435M 11 281M 10 784M 10 822M 10 810M 10 490M
minorityInterest 13M 11M 10M 10M 10M 0
totalLiabilitiesAndTotalEquity 11 435M 11 281M 10 784M 10 822M 10 810M 10 490M
totalInvestments -621M -613M -618M 0 0 0
totalDebt 3 509M 3 366M 2 860M 3 019M 3 097M 3 202M
netDebt 3 313M 3 152M 2 652M 2 810M 2 837M 2 944M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol STE STE STE STE STE STE
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-08 2023-11-07 2023-08-08 2023-03-31 2023-02-08 2022-11-09
acceptedDate 2024-02-08 16:36:30 2023-11-07 16:39:30 2023-08-08 16:53:43 2023-03-31 00:00:00 2023-02-08 16:34:46 2022-11-09 16:38:31
calendarYear 2024.000 2024.000 2024.000 2023.000 2023.000 2023.000
period Q3 Q2 Q1 Q4 Q3 Q2
netIncome 141M 116M 124M 187M 123M -315M
depreciationAndAmortization 141M -20M 138M 0 411M 2850.000
deferredIncomeTax 808 000 -869 000 -445 000 -123M 101 000 -68M
stockBasedCompensation 15M 21M 12M 9M 9M 12M
changeInWorkingCapital -16M -139M 6M 7M -61M -151M
accountsReceivables -16M -45M 42M -100M -30M -29M
inventory -23M -33M -68M 7M -32M -40M
accountsPayables -21M 36M -21M 35M 3M 9M
otherWorkingCapital 44M -97M 52M 67M -1M -91M
otherNonCashItems 9M 169M 2M 135M -277M 627M
netCashProvidedByOperatingActivities 291M 146M 281M 216M 206M 104M
investmentsInPropertyPlantAndEquipment -119M -83M -67M -71M -92M -83M
acquisitionsNet 3M -530M 0 -9M -17M -15M
purchasesOfInvestments 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0
otherInvestingActivites -3M 7M 5000.000 2M 11M 35 000
netCashUsedForInvestingActivites -119M -606M -67M -78M -98M -98M
debtRepayment -15M -15M -15M -15M -106M -15M
commonStockIssued -125M 537M -143M 0 0 0
commonStockRepurchased -2M -489 000 -9M -155M -84M -45M
dividendsPaid -51M -51M -46M -47M -47M -47M
otherFinancingActivites -5M -88 000 -89 000 24M 117M 62M
netCashUsedProvidedByFinancingActivities -198M 470M -214M -192M -120M -45M
effectOfForexChangesOnCash 8M -5M -639 000 3M 14M -19M
netChangeInCash -18M 5M 257 000 -51M 1M -58M
cashAtEndOfPeriod 196M 214M 209M 208M 259M 258M
cashAtBeginningOfPeriod 214M 209M 208M 259M 258M 316M
operatingCashFlow 291M 146M 281M 216M 206M 104M
capitalExpenditure -119M -83M -67M -71M -92M -83M
freeCashFlow 172M 63M 215M 144M 114M 21M
link Link Link Link Link Link
finalLink Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-08 ET (fiscal 2024 q3)
2023 q3
2023-11-08 ET (fiscal 2024 q2)
2023 q2
2023-08-02 ET (fiscal 2024 q1)
2023 q1
2023-05-11 ET (fiscal 2023 q4)
2022 q4
2023-02-09 ET (fiscal 2023 q3)
2022 q3
2022-11-10 ET (fiscal 2023 q2)
2022 q2
2022-08-03 ET (fiscal 2023 q1)
2022 q1
2022-05-12 ET (fiscal 2022 q4)
2021 q4
2022-02-09 ET (fiscal 2022 q3)
2021 q3
2021-11-03 ET (fiscal 2022 q2)
2021 q2
2021-08-10 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-07 21:30 ET
STERIS Announces Financial Results for Fiscal 2024 Third Quarter
2024-01-30 21:30 ET
STERIS Announces Dividend of $0.52 per share
2024-01-23 21:30 ET
STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024
2023-11-07 21:30 ET
STERIS Announces Financial Results for Fiscal 2024 Second Quarter
2023-10-31 22:05 ET
STERIS Announces Dividend of $0.52 per share
2023-10-24 20:30 ET
STERIS to Host a Conference Call for Fiscal 2024 Second Quarter Financial Results on November 8, 2023
2023-08-30 20:30 ET
STERIS to Present at the Morgan Stanley Healthcare Conference
2023-08-02 20:30 ET
STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD
2023-08-01 20:30 ET
STERIS Announces Financial Results for Fiscal 2024 First Quarter
2023-07-26 20:30 ET
STERIS Raises Dividend to $0.52 per share
2023-07-19 20:30 ET
STERIS to Host a Conference Call for Fiscal 2024 First Quarter Financial Results on August 2, 2023
2023-06-20 12:01 ET
BD to Sell Surgical Instrumentation Platform to STERIS
2023-06-20 12:00 ET
STERIS Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Becton, Dickinson and Company for $540 million
2023-05-10 20:30 ET
STERIS Announces Financial Results for Fiscal 2023 Fourth Quarter and Full Year
2023-05-03 20:30 ET
STERIS Appoints Esther M. Alegria, Ph.D. to Board of Directors
2023-05-03 20:30 ET
STERIS Announces $500 million Share Repurchase Authorization and Declares $0.47 per share Dividend
2023-04-24 20:30 ET
STERIS to Host a Conference Call for Fiscal 2023 Fourth Quarter and Full Year Financial Results on May 11, 2023
2023-02-08 21:30 ET
STERIS Announces Financial Results for Fiscal 2023 Third Quarter
2023-02-01 21:52 ET
STERIS Declares $0.47 per share Dividend
2023-01-25 21:30 ET
STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023
2022-11-09 21:30 ET
STERIS Announces Financial Results for Fiscal 2023 Second Quarter
2022-11-02 20:30 ET
STERIS Declares $0.47 per share Dividend
2022-10-25 20:30 ET
STERIS to Host a Conference Call for Fiscal 2023 Second Quarter Financial Results on November 10, 2022
2022-08-02 20:30 ET
STERIS Announces Financial Results for Fiscal 2023 First Quarter
2022-07-28 20:30 ET
STERIS Raises Dividend to $0.47 per share
2022-07-20 20:30 ET
STERIS to Host a Conference Call for Fiscal 2023 First Quarter Financial Results on August 3, 2022
2022-05-11 20:30 ET
STERIS Announces Financial Results for Fiscal 2022 Fourth Quarter and Full Year
2022-05-04 20:30 ET
STERIS Declares $0.43 per share Dividend
2022-04-25 20:30 ET
STERIS to Host a Conference Call for Fiscal 2022 Fourth Quarter and Full Year Financial Results on May 12, 2022
2022-02-08 21:30 ET
STERIS Announces Financial Results for Fiscal 2022 Third Quarter
2022-01-31 21:30 ET
STERIS Declares $0.43 per share Dividend
2022-01-25 21:30 ET
STERIS to Host a Conference Call for Fiscal 2022 Third Quarter Financial Results on February 9, 2022
2022-01-03 21:15 ET
Evoqua Water Technologies Closes Acquisition of Renal Business from STERIS
2021-12-20 12:00 ET
Evoqua Water Technologies Signs Definitive Agreement to Acquire Renal Business from STERIS
2021-11-02 20:30 ET
STERIS Announces Financial Results for Fiscal 2022 Second Quarter
2021-10-28 20:30 ET
STERIS Declares $0.43 per share Dividend
2021-10-20 20:30 ET
STERIS to Host a Conference Call for Fiscal 2022 Second Quarter Financial Results on November 3, 2021
2021-08-09 20:30 ET
STERIS Announces Financial Results for Fiscal 2022 First Quarter
2021-07-27 13:07 ET
STERIS to Host a Conference Call for Fiscal 2022 First Quarter Financial Results on August 10, 2021
2021-06-02 13:00 ET
STERIS Completes the Acquisition of Cantel Medical
2021-05-18 20:30 ET
STERIS Announces Financial Results for Fiscal 2021 Fourth Quarter and Full Year
2021-05-11 20:30 ET
STERIS Announces Changes to Board of Directors
2021-04-27 20:51 ET
STERIS to Host a Conference Call for Fiscal 2021 Fourth Quarter and Full Year Financial Results on May 19, 2021
2021-04-27 11:00 ET
STERIS Announces Preliminary Financial Results for Fiscal 2021
2021-03-09 12:00 ET
Cantel Medical Reports Strong Financial Results for its Second Quarter Fiscal Year 2021
2021-02-03 12:00 ET
STERIS Announces Leadership Succession Plan
2021-02-02 21:30 ET
STERIS Announces Financial Results for Fiscal 2021 Third Quarter
2021-01-19 21:30 ET
STERIS to Host a Conference Call for Fiscal 2021 Third Quarter Financial Results on February 3, 2021
2021-01-12 12:12 ET
STERIS Announces Definitive Agreement to Acquire Cantel Medical
2021-01-07 22:14 ET
STERIS To Participate in Upcoming Investor Conferences
2020-11-18 21:30 ET
STERIS Completes Acquisition of Key Surgical
2020-11-02 21:30 ET
STERIS Announces Financial Results for Fiscal 2021 Second Quarter
2020-10-20 11:00 ET
STERIS to Host a Conference Call for Fiscal 2021 Second Quarter Financial Results on November 3, 2020
2020-10-06 11:00 ET
STERIS Expands Healthcare Consumables Offering with Acquisition of Key Surgical for approximately $850 million

SEC forms

Show financial reports only

SEC form 10
2024-02-08 00:00 ET
STERIS reported for 2023 q4
SEC form 8
2024-02-07 00:00 ET
STERIS published news for 2023 q4
SEC form 8
2024-02-07 00:00 ET
STERIS published news for 2023 q4
SEC form 10
2023-11-07 16:39 ET
STERIS reported for 2023 q3
SEC form 8
2023-11-07 16:35 ET
STERIS published news for 2023 q3
SEC form 10
2023-11-07 00:00 ET
STERIS published news for 2023 q3
SEC form 10
2023-08-08 00:00 ET
STERIS published news for 2023 q2
SEC form 6
2023-08-01 16:45 ET
STERIS reported for 2023 q2
SEC form 8
2023-08-01 00:00 ET
STERIS published news for 2023 q2
SEC form 6
2023-07-27 16:33 ET
STERIS published news for 2023 q2
SEC form 6
2023-07-27 16:30 ET
STERIS published news for 2023 q2
SEC form 6
2023-06-23 16:06 ET
STERIS published news for 2023 q1
SEC form 6
2023-06-20 08:16 ET
STERIS published news for 2023 q1
SEC form 10
2023-05-26 00:00 ET
STERIS published news for 2023 q1
SEC form 8
2023-05-10 00:00 ET
STERIS reported for 2023 q1
SEC form 10
2023-02-08 16:34 ET
STERIS reported for 2022 q4
SEC form 6
2023-02-08 16:33 ET
STERIS published news for 2022 q4
SEC form 8
2023-02-08 00:00 ET
STERIS reported for 2022 q4
SEC form 10
2023-02-08 00:00 ET
STERIS reported for 2022 q4
SEC form 10
2022-11-09 16:38 ET
STERIS reported for 2022 q3
SEC form 6
2022-11-09 16:35 ET
STERIS published news for 2022 q3
SEC form 10
2022-11-09 00:00 ET
STERIS reported for 2022 q3
SEC form 8
2022-11-09 00:00 ET
STERIS reported for 2022 q3
SEC form 10
2022-08-08 16:33 ET
STERIS reported for 2022 q2
SEC form 10
2022-08-08 00:00 ET
STERIS reported for 2022 q2
SEC form 6
2022-08-02 16:34 ET
STERIS published news for 2022 q2
SEC form 8
2022-08-02 00:00 ET
STERIS reported for 2022 q2
SEC form 6
2022-07-29 16:31 ET
STERIS published news for 2022 q2
SEC form 6
2022-06-24 16:35 ET
STERIS published news for 2022 q1
SEC form 6
2022-06-07 16:31 ET
STERIS published news for 2022 q1
SEC form 10
2022-05-31 09:26 ET
STERIS published news for 2022 q1
SEC form 10
2022-05-31 00:00 ET
STERIS published news for 2022 q1
SEC form 8
2022-05-12 00:00 ET
STERIS reported for 2022 q1
SEC form 6
2022-05-11 17:33 ET
STERIS published news for 2022 q1
SEC form 10
2022-02-09 08:14 ET
STERIS published news for 2021 q4
SEC form 10
2022-02-09 00:00 ET
STERIS published news for 2021 q4
SEC form 6
2022-02-08 16:36 ET
STERIS published news for 2021 q4
SEC form 8
2022-02-08 00:00 ET
STERIS published news for 2021 q4
SEC form 6
2022-01-04 06:30 ET
STERIS published news for 2021 q4
SEC form 6
2021-12-20 07:05 ET
STERIS published news for 2021 q3
SEC form 10
2021-11-08 08:39 ET
STERIS published news for 2021 q3
SEC form 10
2021-11-08 00:00 ET
STERIS published news for 2021 q3
SEC form 6
2021-11-02 16:46 ET
STERIS published news for 2021 q3
SEC form 8
2021-11-02 00:00 ET
STERIS published news for 2021 q3
SEC form 10
2021-08-09 16:54 ET
STERIS published news for 2021 q2
SEC form 6
2021-08-09 16:49 ET
STERIS published news for 2021 q2
SEC form 8
2021-08-09 00:00 ET
STERIS published news for 2021 q2
SEC form 10
2021-08-09 00:00 ET
STERIS published news for 2021 q2
SEC form 6
2021-08-02 16:37 ET
STERIS published news for 2021 q2
SEC form 6
2021-08-02 16:31 ET
STERIS published news for 2021 q2
SEC form 6
2021-06-15 16:25 ET
STERIS published news for 2021 q1
SEC form 6
2021-06-08 16:51 ET
STERIS published news for 2021 q1
SEC form 6
2021-06-07 16:59 ET
STERIS published news for 2021 q1
SEC form 6
2021-06-04 16:42 ET
STERIS published news for 2021 q1
SEC form 6
2021-06-02 16:58 ET
STERIS published news for 2021 q1
SEC form 10
2021-05-28 07:46 ET
STERIS published news for 2021 q1
SEC form 10
2021-05-28 00:00 ET
STERIS published news for 2021 q1
SEC form 6
2021-05-18 16:36 ET
STERIS published news for 2021 q1
SEC form 8
2021-05-18 00:00 ET
STERIS published news for 2021 q1
SEC form 6
2021-05-11 16:46 ET
STERIS published news for 2021 q1
SEC form 6
2021-04-27 07:11 ET
STERIS published news for 2021 q1
SEC form 8
2021-04-27 00:00 ET
STERIS published news for 2021 q1
SEC form 6
2021-04-01 09:25 ET
STERIS published news for 2021 q1
SEC form 6
2021-03-23 08:34 ET
STERIS published news for 2020 q4
SEC form 6
2021-02-09 08:21 ET
STERIS published news for 2020 q4
SEC form 10
2021-02-09 08:00 ET
STERIS published news for 2020 q4
SEC form 6
2021-02-03 07:17 ET
STERIS published news for 2020 q4
SEC form 6
2021-02-02 16:41 ET
STERIS published news for 2020 q4
SEC form 6
2021-01-12 17:19 ET
STERIS published news for 2020 q4
SEC form 6
2020-11-18 17:20 ET
STERIS published news for 2020 q3
SEC form 10
2020-11-06 08:28 ET
STERIS published news for 2020 q3
SEC form 6
2020-11-02 16:36 ET
STERIS published news for 2020 q3
SEC form 6
2020-10-06 07:24 ET
STERIS published news for 2020 q3